Sponsored Links

FDA Issues Another Emergency Use Authorization For Commercial H1N1 Flu Test To Quest Diagnostics' Focus Diagnostics PDF Print E-mail
Medical News - Medical Devices and Diagnostics
The U.S. Food and Drug Administration (FDA) issued a second emergency use authorization (EUA) to Focus Diagnostics, the infectious disease diagnostics business of Quest Diagnostics Incorporated (NYSE: DGX), for its 2009 H1N1 influenza virus test. With the EUA, Focus Diagnostics is the only company in the U.S.

Read more: Medical Devices / Diagnostics News From Medical News Today